CIK 0001175151 · Non-accelerated filer<br>Smaller reporting company
Cytosorbents Corp
Sign in to watch- Ticker
- CTSO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980373793
- Phone
- 973-329-8885
- Business address
- 305 COLLEGE ROAD EAST, PRINCETON, NJ, 08540
- Former names
- MedaSorb Technologies CORP, GILDER ENTERPRISES INC
- Open-market buys, last 90 days
- $120,435
- in 4 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$120,435. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2009-10-05 | NJTC INVESTMENT FUND, LP 10% owner | Option exercise · Warrant (right to buy) | −100 | 200 | ||
| 2009-10-05 | NJTC INVESTMENT FUND, LP 10% owner | Option exercise · Series B 10% Convertible Preferred Stock | +100 | 1,006.38 | ||
| 2009-01-28 | Kraus Al Director | Grant or award · Stock Option | +450,000 | 8,663,370 | ||
| 2009-01-28 | Lamadrid David Chief Financial Officer | Grant or award · Stock Option | +400,000 | 4,700,000 | ||
| 2009-01-28 | Capponi Vincent Chief Operating Officer | Grant or award · Stock Option | +400,000 | 3,800,000 | ||
| 2009-01-08 | Kraus Al Director | Grant or award · Stock Option | +200,000 | 8,213,370 | ||
| 2009-01-08 | Chan Phillip P. Interim CEO | Grant or award · Stock Option | +2,503,858 | 2,518,858 | ||
| 2008-12-31 | NJTC INVESTMENT FUND, LP 10% owner | Grant or award · Stock Option (right to buy) | +600 | 600 | ||
| 2008-12-31 | Jones Edward Raymond Director | Grant or award · Stock Option | +30,000 | 82,500 | ||
| 2008-12-31 | Rubin Joseph Director | Grant or award · Stock Option | +30,000 | 146,715 | ||
| 2008-12-31 | Gunton James T. Director | Grant or award · Stock Option | +15,000 | 15,000 | ||
| 2008-12-31 | Chan Phillip P. Interim CEO | Grant or award · Stock Option | +15,000 | 15,000 | ||
| 2008-06-25 | MILLER WILLIAM R Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2008-06-25 | Katz Kurt Director | Grant or award · Stock Option (Right to Buy) | +45,000 | 45,000 | ||
| 2008-06-25 | Rubin Joseph Director | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2008-06-25 | Winchester James F Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +356,250 | 356,250 | ||
| 2008-06-25 | Lamadrid David Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +2,750,000 | 2,750,000 | ||
| 2008-06-25 | Jones Edward Raymond Director | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2008-06-25 | Kraus Al President & CEO | Grant or award · Stock Option (Right to Buy) | +7,119,328 | 7,119,328 | ||
| 2008-06-25 | Capponi Vincent Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +2,250,000 | 2,250,000 |
Page 37 of 39 · 774 trades